Federal Enforcement Updates Impacting the Life Sciences Industry: DOJ Investigations, Cybersecurity, and Gender-Affirming Care

Event Details

Federal regulators, including the U.S. Department of Justice (“DOJ”) and the U.S. Department of Health and Human Services (“HHS”), are increasing scrutiny in areas such as healthcare fraud, cybersecurity compliance, and gender-affirming care. New enforcement initiatives and regulatory actions are creating challenges for organizations managing compliance obligations and government investigations. For healthcare and life sciences companies, understanding these enforcement priorities is essential to managing risk and preparing for potential government scrutiny.

Gain Insights From a Former DOJ Enforcement Leader

On May 5, 2026, please join AGG Life Sciences co-chair and Gender-Affirming Care Investigations Response Team leader, Gabe Scannapieco, for a timely webinar on emerging enforcement developments affecting the life sciences sector. A former assistant director of the DOJ Consumer Protection Branch, Gabe will share practical insight into how regulators evaluate potential violations and actionable steps companies can take in light of changing federal enforcement priorities.

The session will be moderated by AGG Food & Drug leader and Life Sciences co-chair, Alan Minsk.

What You Will Learn

• 2026 DOJ Enforcement Trends in Life Sciences and Healthcare: Explore heightened coordination across federal and state regulators and a growing focus on system-wide compliance risks.
• DOJ’s Division for National Fraud Enforcement: Understand how the DOJ’s newly created division may affect investigations involving pharmaceutical, medical device, and healthcare companies.
• Cybersecurity Investigations: Learn how federal agencies are expanding oversight of cybersecurity incidents, data protection practices, and breach response, and what this means for companies handling sensitive health and patient data.
• Gender-Affirming Care Enforcement: Get the latest insights on federal enforcement activity following recent HHS announcements, including potential regulatory and investigative risks for healthcare providers and life sciences companies.
• Preparing for Government Investigations: Discover practical strategies to strengthen compliance programs.

There will be an opportunity for Q&A at the end of this webinar.

Credits: 1 hour of CLE credit is pending approval by the State Bar of Georgia.